Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Every even year , the ESC Working Group on Atherosclerosis and Vascular Biology organises a one day symposium to gathers top level international speakers in the Working Group field.
Held one day prior to the Frontiers in CardioVascular Biology (FCVB) Congress, the symposium provides to young scientists an overview of current research in atherosclerosis and vascular biology at experimental and clinical level. It is also the entry point to FCVB, the official Congress of the Council on Basic Cardiovascular Science, which is one of the most relevant exchange platforms for basic and translational cardiovascular biology.
At the end of the symposium and thanks to the hard work on the scientific content, the Working Group nucleus and the symposium speakers meet to form the basis of a Position Paper.
The application of the rapidly evolving field of single-cell technologies like CyTOF and single-cell RNAseq is allowing identification of novel cell communities that are important in CVD. Based on recent and many ongoing studies we will be able to improve patient-at-risk identification and define new therapeutic strategies for treatment of disease.
Join the discussion during the 4th biennial Symposium of the ESC Working Group on Atherosclerosis and Vascular Biology organised just before the Frontiers in CardioVascular Biomedicine (FCVB) Congress.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.